Psoriasis Treatment Market - Global Industry
Insights, Trends, Outlook, and Opportunity Analysis,
2018-2026
Psoriasis is a non-communicable autoimmune disease characterized by patches of abnormal
skin. These skin spots are red, itchy, and scaly which may be small and localized or cover the
entire body. Skin injury may cause psoriatic skin changes at that spot, a phenomenon called
Koebner phenomenon.
Request Sample Copy of Research Report @
https://www.coherentmarketinsights.com/insight/request-sample/99
There are five main types of psoriasis namely Plaque, Guttate, Inverse, Pustular,
and Erythrodermic. Plaque psoriasis, also known as psoriasis vulgaris, is the most prevalent
type of psoriasis, accounting for around 90% of reported cases. Most commonly affected areas
of the body include back of the forearms, shins, around the navel, and the scalp. Guttate
psoriasis has drop-shaped lesions. Pustular psoriasis is characterized by the presence of small
non-infectious pus-filled blisters. Inverse psoriasis forms red patches in skin folds. Erythrodermic
psoriasis occurs when the rash become widespread and can develop from other
types. Fingernails and toenails are affected in most people at some point of time. This may
include pits in the nails or changes in nail color.
Treatment options for Psoriasis fueling growth of the psoriasis treatment market
Various treatments can help control the symptoms fueling growth of psoriasis treatment
market. These treatment methods include administering steroid, vitamin D3, exposure to
ultraviolet B (UVB) light, and immunosuppressive like methotrexate. Around 75% of cases can
be managed with creams alone. Cream and ointments of corticosteroid, and calcipotriol can
effectively treat mild-to-moderate psoriasis. However, when condition become more severe,
creams are combined with oral medications such as methotrexate, acitretin, and cyclosporin.
Topical drugs used in treatment of psoriasis include corticosteroids, vitamin D,
hydroxyanthrone, and retinoid aiding in growth of the psoriasis treatment market. Topical
corticosteroids are frequently prescribed for treating mild-to-moderate psoriasis. Low-potency